Acuta Capital Partners’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-30,000	Closed	-$201K	–	38
2022 Q3	$201K	Buy	+30,000	New	+$201K	0.09%	37
2018 Q3	–	Hold	0	–	–	–	28
2018 Q2	–	Hold	0	–	–	–	44